LINC-ROR and breast carcinoma: linc‐ROR is an important marker for multidrug resistance in breast cancer, and its upregulation is important for chemotherapy tolerance (Chen et al., 2016a), and it confers the resistance of breast cancer cells to gemcitabine by silencing miR‐34a expression (Chen et al., 2016b).